RxDoctor Payments Data

Kryn Sisco

Psychiatric/Mental Health · Lansing, MINPI 1245296326

Payments from drug & device makers

$2,080in general payments, 2019–2025

Across 75 payments — averaging $27.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$513
  • Alkermes, Inc.$331
  • Axsome Therapeutics, Inc.$235
  • Teva Pharmaceuticals USA, Inc.$223
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$210
  • Otsuka America Pharmaceutical, Inc.$166
  • plus $401 from 8 others

What the payments were for

  • Food & beverage$2,080100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,080 in reported general payments places this provider in the 75th percentile of 638 psychiatric/mental health providers in Michigan.

See all psychiatric/mental health providers in Michigan

Medicare billing

Part B allowed, 2024
$16,853
Medicare patients
79
Services billed
306

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate23$58,602
Paliperidone ErPaliperidone36$4,257
Clozapine60$2,704
Aripiprazole119$2,411
Risperidone197$1,782
Quetiapine Fumarate182$1,743
Olanzapine152$1,610
Sertraline Hcl195$1,430
Vilazodone Hcl18$1,350
Mirtazapine78$1,331
Duloxetine Hcl85$1,018
Fluoxetine Hcl135$966
Paroxetine Hcl104$952
Trazodone Hcl103$877
Risperidone OdtRisperidone18$788

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$513$58,60223 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 638 psychiatric/mental health providers in Michigan.

Other psychiatric/mental health in Lansing

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →